Excenen PharmaTech is dedicated to serve the pharmaceutical, scientific research and development industries from 2010.

Our chemists had successfully synthesized PF-07321332  (Cat#:EX-A5024) (purity: 96.99% by HPLC, 1st batch) in July 2021. Then in August we got the 2nd batch with higher purity (98.37% by HPLC).

PF-07321332 (Cat#:EX-A5024) is in stock now.

We've already supplied this compound to scientists from USA, Canada, Korea, UK etc. As of September 26, all customers’ feedback shows the compound (PF-07321332 Cat#:EX-A5024) worked well during their experiments.

PF-07321332 is an orally bioavailable 3C-like protease (3CLPRO) inhibitor. PF-07321332 is an oral COVID-19 antiviral clinical candidate. By inhibiting the main protease, PF-07321332 prevents the virus from cleaving long protein chains into the parts it needs to reproduce itself.

All test report can be provided upon email request, please email us at [email protected] to request the analytical reports.